WST West Pharmaceutical
- Official Name: WEST PHARMACEUTICAL SERVICES, INC.
- Headquarters: 530 Herman O. West Drive, EXTON, PA, 19341 US
- CEO: Eric Green
- Website: westpharma.com
- Key Investor: VANGUARD GROUP INC | 12.77%
- Dedicated Investor: LTS ONE MANAGEMENT LP | 7.35%
Match Results
| Date | League | Week | Opponent | Result | Score |
|---|---|---|---|---|---|
| 2025-07-14 | 1 | Won by 1.769 | 0.941 - (0.828) | ||
| 2025-07-21 | 2 | Lost by 9.724 | (6.284) - 3.440 | ||
| 2025-07-28 | 3 | Won by 17.348 TOTW | 23.911 - 6.563 | ||
| 2025-07-29 | 2R | Lost by 0.034 | (0.914) - (0.880) | ||
| 2025-08-04 | 4 | Won by 2.392 | (4.249) - (6.641) | ||
| 2025-08-07 | 1R | Won by 2.813 | 1.212 - (1.601) | ||
| 2025-08-11 | 5 | Won by 0.545 | 1.764 - 1.219 | ||
| 2025-08-18 | 6 | Won by 0.414 | 1.404 - 0.990 | ||
| 2025-08-20 | 1R | Won by 3.479 | (0.044) - (3.523) | ||
| 2025-08-21 | 2R | Lost by 0.117 | (0.912) - (0.795) | ||
| 2025-08-25 | 7 | Won by 1.016 | 1.936 - 0.920 | ||
| 2025-09-01 | 8 | Won by 5.044 | (0.118) - (5.162) | ||
| 2025-09-03 | 2R | Lost by 0.172 | 2.271 - 2.443 | ||
| 2025-09-08 | 9 | Won by 2.257 | 2.967 - 0.710 | ||
| 2025-09-15 | 10 | Won by 1.499 | 1.735 - 0.236 | ||
| 2025-09-22 | 11 | Lost by 8.379 | (1.880) - 6.499 | ||
| 2025-09-29 | 12 | Won by 5.315 | 3.106 - (2.209) | ||
| 2025-10-06 | 13 | Lost by 13.900 | 2.847 - 16.747 | ||
| 2025-10-13 | 14 | Lost by 0.993 | (2.064) - (1.071) | ||
| 2025-10-20 | 15 | Won by 1.691 | 4.845 - 3.154 |
Latest News

Stryker to Acquire ZuriMED to Expand Its Shoulder Care Portfolio
SYK's planned ZuriMED acquisition adds the FiberLocker System, aiming to strengthen its shoulder portfolio and rotator cuff care capabilities.

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences
10x Genomics wins a $4.8M patent verdict against Parse, strengthening its IP position as it seeks added damages and a U.S. injunction.

GE HealthCare Unveils Next-Gen Vivid Cardiac Ultrasound Systems
GEHC expands its Vivid cardiovascular ultrasound portfolio with three systems featuring AI tools and cSound imaging for varied care settings.

CVRx Secures Devoted Health Coverage for Barostim Therapy
CVRX secures Devoted Health Medicare Advantage coverage for Barostim, expanding reimbursement access to about 466,000 members across 29 states.

Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Natera & Angiex Partner to Evaluate AGX101 Response With Signatera
NTRA teams with Angiex to use Signatera in a Phase 1 AGX101 trial, aiming to track ctDNA and deepen insights into treatment response.

Best Dividend Aristocrats For September 2026
Dividend Aristocrats (NOBL) nearly match SPY in 2026, with top gainers, rising dividend growth, and 29 undervalued picksâsee which to buy now.